Fatigue in XXXX With @entity3458 : Association With Neurocognitive and Social-Emotional Functioning and Quality of Life.

@entity1 @entity283 @entity3458 @entity1295 @entity158 @entity1118
UNASSIGNED: @entity1 with @entity3458 ( @entity3458 ) report @entity1295 in addition to acute and @entity1118 , which can decrease overall @entity283 ( @entity283 ). The primary objective of the current study was to investigate the relationship between @entity1295 and @entity283 . Given limited prior research, secondary objectives included investigation of associations between @entity1295 and functional outcomes, including @entity1 neurocognitive and social-emotional functioning. @entity1 aged 8 to 16 years (N=32) and a caregiver completed measures of @entity1295 , @entity283 , @entity158 , and neurocognitive and social-emotional functioning. Controlling for @entity158 and number of @entity3458 -related hospitalizations, hierarchical linear regression models were used to determine the impact of @entity1 -reported and parent-reported @entity1295 on @entity1 @entity283 . Correlational analyses were used to explore the relationship between @entity1295 and additional @entity1 outcomes. Data indicated that @entity1 with @entity3458 experience clinically relevant levels of @entity1295 , which independently predicts lower @entity283 . Fatigue was also associated with lower working memory, executive functioning, and higher levels of internalizing symptoms. Given its observed impact on @entity283 and relationship to functional outcomes, @entity1295 may be an important target of clinical, home, or school interventions. This practice may attenuate the burden of @entity1295 in these @entity1 , and in turn, help improve the quality of life of @entity1 living with @entity3458 .
